Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke

Current Medicinal Chemistry

Volumn 16, Issue 34, 2009, Pages 4593-4600

  Shi, Honglian ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Antioxidant; Cerebral ischemia; Free radical; HIF 1; Neuroprotection; Stroke

Indexed keywords

ALTEPLASE; ANTIOXIDANT; CYTOCHROME C; DEFEROXAMINE; DIMETHYLOXALYLGLYCINE; DISUFENTON SODIUM; EBSELEN; ENZYME INHIBITOR; ERYTHROPOIETIN; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NORPHENAZONE; PROTEIN P53; PROTOCATECHUIC ACID; REACTIVE OXYGEN METABOLITE; TIRILAZAD; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; UNCLASSIFIED DRUG; URIC ACID; VASCULOTROPIN;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; BLEEDING DISORDER; BRAIN ISCHEMIA; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG TARGETING; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HUMAN; MOLECULAR MECHANICS; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; REVIEW;

ANIMALS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; PROTEASOME ENDOPEPTIDASE COMPLEX; REACTIVE OXYGEN SPECIES; STROKE;

EID: 72449163624     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709789760779     Document Type: Review

References (119)

1. Wiener, C.M.; Booth, G.; Semenza, G.L. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun., 1996, 2, 485-488. (Pubitemid 26355627)
2. Bernaudin, M.; Nedelec, A.S.; Divoux, D.; MacKenzie, E.T.; Petit, E.; Schumann-Bard, P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow. Metab., 2002, 4, 393-403. (Pubitemid 34273595)
3. Stroka, D.M.; Burkhardt, T.; Desbaillets, I.; Wenger, R.H.; Neil, D.A.; Bauer, C.; Gassmann, M.; Candinas, D. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J., 2001, 13, 2445-2453. (Pubitemid 33063172)
4. Jones, N.M.; Bergeron, M. Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J. Cerebr. Blood Flow Metab., 2001, 9, 1105-1114. (Pubitemid 32823746)
5. Pichiule, P.; Agani, F.; Chavez, J.C.; Xu, K.; LaManna, J.C. HIF- 1α and VEGF expression after transient global cerebral ischemia. Adv. Exp. Med. Biol., 2003, 611-617. (Pubitemid 37352402)
6. Bergeron, M.; Yu, A.Y.; Solway, K.E.; Semenza, G.L.; Sharp, F.R. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eu. J. Neurosci., 1999, 12, 4159-4170.
7. Demougeot, C.; Van Hoecke, M.; Bertrand, N.; Prigent-Tessier, A.; Mossiat, C.; Beley, A.; Marie, C. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2′-dipyridyl in the rat photothrombotic ischemic stroke model. J. Pharmacol. Exp. Ther., 2004, 3, 1080-1087. (Pubitemid 39612714)
8. Baranova, O.; Miranda, L.F.; Pichiule, P.; Dragatsis, I.; Johnson, R.S.; Chavez, J.C. Neuron-specific inactivation of the hypoxia inducible factor 1α increases brain injury in a mouse model of transient focal cerebral ischemia. J. Neurosci., 2007, 23, 6320-6332.
9. Ruscher, K.; Isaev, N.; Trendelenburg, G.; Weih, M.; Iurato, L.; Meisel, A.; Dirnagl, U. Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neurosci. Lett., 1998, 2, 117-120. (Pubitemid 28454846)
10. Sharp, F.R.; Bernaudin, M. HIF-I and oxygen sensing in the brain. Nature Rev. Neurosci., 2004, 6, 437-448.
11. Semenza, G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer, 2003, 10, 721-732.
12. Semenza, G.L. Angiogenesis in ischemic and neoplastic disorders. Ann. Rev. Med., 2003, 17-28.
13. Bernaudin, M.; Tang, Y.; Reilly, M.; Petit, E.; Sharp, F.R. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia- induced ischemic tolerance. J. Biol. Chem., 2002, 42, 39728-39738.
14. Miller, B.A.; Perez, R.S.; Shah, A.R.; Gonzales, E.R.; Park, T.S.; Gidday, J.M. Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport, 2001, 8, 1663-1669.
15. Prass, K.; Ruscher, K.; Karsch, M.; Isaev, N.; Megow, D.; Priller, J.; Scharff, A.; Dirnagl, U.; Meisel, A. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood. Flow. Metab., 2002, 5, 520-525. (Pubitemid 34477773)
16. Gidday, J.M.; Shah, A.R.; Maceren, R.G.; Wang, Q.; Pelligrino, D.A.; Holtzman, D.M.; Park, T.S. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J. Cereb. Blood Flow Metab., 1999, 3, 331-340.
17. Siddiq, A.; Ayoub, I.A.; Chavez, J.C.; Aminova, L.; Shah, S.; La-Manna, J.C.; Patton, S.M.; Connor, J.R.; Cherny, R.A.; Volitakis, I.; Bush, A.I.; Langsetmo, I.; Seeley, T.; Gunzler, V.; Ratan, R.R. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J. Biol. Chem., 2005, 50, 41732-41743.
18. Zaman, K.; Ryu, H.; Hall, D.; O'Donovan, K.; Lin, K.I.; Miller, M.P.; Marquis, J.C.; Baraban, J.M.; Semenza, G.L.; Ratan, R.R. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J. Neurosci., 1999, 22, 9821-9830.
19. Hamrick, S.E.; McQuillen, P.S.; Jiang, X.; Mu, D.; Madan, A.; Ferriero, D.M. A role for hypoxia-inducible factor-1α in desferoxamine neuroprotection. Neurosci. Lett., 2005, 2, 96-100. (Pubitemid 40501388)
20. Freret, T.; Valable, S.; Chazalviel, L.; Saulnier, R.; Mackenzie, E.T.; Petit, E.; Bernaudin, M.; Boulouard, M.; Schumann-Bard, P. Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat. Eur. J. Neurosci., 2006, 7, 1757-1765.
21. Siddiq, A.; Aminova, L.R.; Ratan, R.R. Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress. Neurochem. Res., 2007, 4-5, 931-946.
22. Bergeron, M.; Yu, A.Y.; Solway, K.E.; Semenza, G.L.; Sharp, F.R. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci., 1999, 12, 4159-4170.
23. Zhou, D.; Matchett, G.A.; Jadhav, V.; Dach, N.; Zhang, J.H. The effect of 2-methoxyestradiol, a HIF-1α inhibitor, in global cerebral ischemia in rats. Neurol. Res., 2008, 3, 268-271. (Pubitemid 351769420)
24. Guo, S.; Miyake, M.; Liu, K.J.; Shi, H. Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment. J. Neurochem., 2009, 5, 1309-1321.
25. Ehrenreich, H.; Hasselblatt, M.; Dembowski, C.; Cepek, L.; Lewczuk, P.; Stiefel, M.; Rustenbeck, H.H.; Breiter, N.; Jacob, S.; Knerlich, F.; Bohn, M.; Poser, W.; Ruther, E.; Kochen, M.; Gefeller, O.; Gleiter, C.; Wessel, T.C.; De Ryck, M.; Itri, L.; Prange, H.; Cerami, A.; Brines, M.; Siren, A.L. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med., 2002, 8, 495-505.
26. Bernaudin, M.; Marti, H.H.; Roussel, S.; Divoux, D.; Nouvelot, A.; MacKenzie, E.T.; Petit, E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab., 1999, 6, 643-651. (Pubitemid 30161216)
27. Sakanaka, M.; Wen, T.C.; Matsuda, S.; Masuda, S.; Morishita, E.; Nagao, M.; Sasaki, R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. USA, 1998, 8, 4635-4640. (Pubitemid 28207965)
28. Siren, A.L.; Fratelli, M.; Brines, M.; Goemans, C.; Casagrande, S.; Lewczuk, P.; Keenan, S.; Gleiter, C.; Pasquali, C.; Capobianco, A.; Mennini, T.; Heumann, R.; Cerami, A.; Ehrenreich, H.; Ghezzi, P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. USA, 2001, 7, 4044-4049. (Pubitemid 32249895)
29. Marti, H.J.; Bernaudin, M.; Bellail, A.; Schoch, H.; Euler, M.; Petit, E.; Risau, W. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol., 2000, 3, 965-976. (Pubitemid 30626954)
30. Jin, K.L.; Mao, X.O.; Greenberg, D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. USA, 2000, 18, 10242-10247. (Pubitemid 30680886)
31. 2 cells against serum deprivation- and t-BHP-induced apoptosis: a possible anti-apoptotic role for HIF-1. Exp. Cell Res., 2004, 2, 340-349.
32. Sasabe, E.; Tatemoto, Y.; Li, D.; Yamamoto, T.; Osaki, T. Mechanism of HIF-1α -dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci., 2005, 7, 394-402. (Pubitemid 41179740)
33. Li, J.; Zhang, X.; Sejas, D.P.; Bagby, G.C.; Pang, Q. Hypoxiainduced nucleophosmin protects cell death through inhibition of p53. J. Biol. Chem., 2004, 40, 41275-41279. (Pubitemid 39313565)
34. Piret, J.P.; Mottet, D.; Raes, M.; Michiels, C. Is HIF-1α a pro- or an anti-apoptotic protein? Biochem. Pharmacol., 2002, 5-6, 889-892.
35. Lawrence, M.S.; Sun, G.H.; Kunis, D.M.; Saydam, T.C.; Dash, R.; Ho, D.Y.; Sapolsky, R.M.; Steinberg, G.K. Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. J. Cereb. Blood Flow Metab., 1996, 2, 181-185. (Pubitemid 26062808)
36. Koshiji, M.; Kageyama, Y.; Pete, E.A.; Horikawa, I.; Barrett, J.C.; Huang, L.E. HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J., 2004, 9, 1949-1956. (Pubitemid 38902073)
37. Liu, J.; Narasimhan, P.; Lee, Y.S.; Song, Y.S.; Endo, H.; Yu, F.; Chan, P.H. Mild hypoxia promotes survival and proliferation of SOD2-deficient astrocytes via c-Myc activation. J. Neurosci., 2006, 16, 4329-4337.
38. Carmeliet, P.; Dor, Y.; Herbert, J.M.; Fukumura, D.; Brusselmans, K.; Dewerchin, M.; Neeman, M.; Bono, F.; Abramovitch, R.; Maxwell, P.; Koch, C.J.; Ratcliffe, P.; Moons, L.; Jain, R.K.; Collen, D.; Keshert, E.; Keshet, E. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 1998, 6692, 485-490. (Pubitemid 28373960)
39. Halterman, M.W.; Federoff, H.J. HIF-1α and p53 promote hypoxia- induced delayed neuronal death in models of CNS ischemia. Exp. Neurol., 1999, 1, 65-72.
40. Halterman, M.W.; Miller, C.C.; Federoff, H.J. Hypoxia-inducible factor-1α mediates hypoxia-induced delayed neuronal death that involves p53. J. Neurosci., 1999, 16, 6818-6824.
41. Chen, C.; Hu, Q.; Yan, J.; Lei, J.; Qin, L.; Shi, X.; Luan, L.; Yang, L.; Wang, K.; Han, J.; Nanda, A.; Zhou, C. Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1α and apoptotic genes in a middle cerebral artery occlusion-induced focal ischemia rat model. J. Neurochem., 2007, 102, 1831-1841. (Pubitemid 47329256)
42. Mellor, H.R.; Harris, A.L. The role of the hypoxia-inducible BH3- only proteins BNIP3 and BNIP3L in cancer. Cancer Metastasis Rev., 2007, 3-4, 553-566.
43. Helton, R.; Cui, J.; Scheel, J.R.; Ellison, J.A.; Ames, C.; Gibson, C.; Blouw, B.; Ouyang, L.; Dragatsis, I.; Zeitlin, S.; Johnson, R.S.; Lipton, S.A.; Barlow, C. Brain-specific knock-out of hypoxiainducible factor-1α reduces rather than increases hypoxic-ischemic damage. J. Neurosci., 2005, 16, 4099-4107. (Pubitemid 40563385)
44. Chen, W.; Ostrowski, R.P.; Obenaus, A.; Zhang, J.H. Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury. Exp. Neurol., 2009, 1, 7-15.
45. Palmer, L.A.; Semenza, G.L.; Stoler, M.H.; Johns, R.A. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am. J. Physiol., 1998, 2 Pt 1, L212-219.
46. Millhorn, D.E.; Raymond, R.; Conforti, L.; Zhu, W.; Beitner-Johnson, D.; Filisko, T.; Genter, M.B.; Kobayashi, S.; Peng, M. Regulation of gene expression for tyrosine hydroxylase in oxygen sensitive cells by hypoxia. Kidney Intl., 1997, 2, 527-535. (Pubitemid 27088170)
47. Semenza, G.L.; Jiang, B.H.; Leung, S.W.; Passantino, R.; Concordet, J.P.; Maire, P.; Giallongo, A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem., 1996, 51, 32529-32537. (Pubitemid 27008669)
48. 2 tension. Proc. Natl. Acad. Sci. USA, 1995, 12, 5510-5514.
49. Wood, S.M.; Gleadle, J.M.; Pugh, C.W.; Hankinson, O.; Ratcliffe, P.J. The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells. J. Biol. Chem., 1996, 25, 15117-15123. (Pubitemid 26197580)
50. Jiang, B.H.; Rue, E.; Wang, G.L.; Roe, R.; Semenza, G.L. Dimerization, DNA binding, and transactivation properties of hypoxiainducible factor 1. J. Biol. Chem., 1996, 30, 17771-17778. (Pubitemid 26250751)
51. Pugh, C.W.; O'Rourke, J.F.; Nagao, M.; Gleadle, J.M.; Ratcliffe, P.J. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. J. Biol. Chem., 1997, 17, 11205-11214.
52. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA, 1998, 14, 7987-7992.
53. Kallio, P.J.; Wilson, W.J.; O'Brien, S.; Makino, Y.; Poellinger, L. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem., 1999, 10, 6519-6525. (Pubitemid 29111068)
54. Salceda, S.; Caro, J. Hypoxia-inducible factor 1α protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 1997, 36, 22642-22647. (Pubitemid 27386079)
55. 2 tension. Am. J. Physiol., 1996, 4 Pt 1, C1172-1180.
56. Chandel, N.S.; Schumacker, P.T. Cellular oxygen sensing by mitochondria: old questions, new insight. J. Applied Physiol., 2000, 5, 1880-1889.
57. Fandrey, J.; Frede, S.; Ehleben, W.; Porwol, T.; Acker, H.; Jelkmann, W. Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoietin production by reactive oxygen species. Kidney Intl., 1997, 2, 492-496. (Pubitemid 27088165)
58. Chandel, N.S.; Maltepe, E.; Goldwasser, E.; Mathieu, C.E.; Simon, M.C.; Schumacker, P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA, 1998, 20, 11715-11720.
59. Duranteau, J.; Chandel, N.S.; Kulisz, A.; Shao, Z.; Schumacker, P.T. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J. Biol. Chem., 1998, 19, 11619-11624. (Pubitemid 28272061)
60. Pearlstein, D.P.; Ali, M.H.; Mungai, P.T.; Hynes, K.L.; Gewertz, B.L.; Schumacker, P.T. Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia. Arterioscl. Thromb.Vasc. Biol., 2002, 4, 566-573.
61. Grishko, V.; Solomon, M.; Breit, J.F.; Killilea, D.W.; Ledoux, S.P.; Wilson, G.L.; Gillespie, M.N. Hypoxia promotes oxidative base modifications in the pulmonary artery endothelial cell VEGF gene. FASEB J., 2001, 7, 1267-1269.
62. Turcotte, S., Desrosiers, R.R., BEliveau, R. HIF-1α mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma. J. Cell Sci., 2003, 11, 2247-2260. (Pubitemid 36722371)
63. Huang, L.E.; Arany, Z.; Livingston, D.M.; Bunn, H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem., 1996, 50, 32253-32259.
64. Carrero, P.; Okamoto, K.; Coumailleau, P.; O'Brien, S.; Tanaka, H.; Poellinger, L. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxiainducible factor 1α. Mol. Cell Biol., 2000, 1, 402-415. (Pubitemid 30002581)
65. Liu, Q.; Berchner-Pfannschmidt, U.; Moller, U.; Brecht, M.; Wotzlaw, C.; Acker, H.; Jungermann, K.; Kietzmann, T. A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc. Natl. Acad. Sci. USA, 2004, 12, 4302-4307. (Pubitemid 38405924)
66. Haddad, J.J.; Olver, R.E.; Land, S.C. Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-kB redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J. Biol. Chem., 2000, 28, 21130-21139.
67. Haddad, J.J. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal., 2002, 11, 879-897. (Pubitemid 35247561)
68. Welsh, S.J.; Bellamy, W.T.; Briehl, M.M.; Powis, G. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1α protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res., 2002, 17, 5089-5095. (Pubitemid 34984438)
69. Grune, T.; Reinheckel, T.; North, J.A.; Li, R.; Bescos, P.B.; Shringarpure, R.; Davies, K.J. Ezrin turnover and cell shape changes catalyzed by proteasome in oxidatively stressed cells. FASEB J, 2002, 12, 1602-1610.
70. Jahngen-Hodge, J.; Obin, M.S.; Gong, X.; Shang, F.; Nowell, T.R., Jr.; Gong, J.; Abasi, H.; Blumberg, J.; Taylor, A. Regulation of ubiquitin- conjugating enzymes by glutathione following oxidative stress. J. Biol. Chem., 1997, 45, 28218-28226. (Pubitemid 27517760)
71. Huang, L.E.; Bunn, H.F. Hypoxia-inducible factor and its biomedical relevance. J. Biol. Chem., 2003, 22, 19575-19578.
72. Guo, S.; Bragina, O.; Xu, Y.; Cao, Z.; Chen, H.; Zhou, B.; Morgan, M.; Lin, Y.; Jiang, B.H.; Liu, K.J.; Shi, H. Glucose up-regulates HIF-1α expression in primary cortical neurons in response to hypoxia through maintaining cellular redox status. J. Neurochem., 2008, 5, 1849-1860. (Pubitemid 351678509)
73. Demidenko, Z.N.; Rapisarda, A.; Garayoa, M.; Giannakakou, P.; Melillo, G.; Blagosklonny, M.V. Accumulation of hypoxiainducible factor-1α is limited by transcription-dependent depletion. Oncogene, 2005, 30, 4829-4838.
74. Kong, X.; Alvarez-Castelao, B.; Lin, Z.; Castano, J.G.; Caro, J. Constitutive/hypoxic degradation of HIF-1α proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein. J. Biol. Chem., 2007, 21, 15498-15505. (Pubitemid 47093272)
75. Slemmer, J.E.; Shacka, J.J.; Sweeney, M.I.; Weber, J.T. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr. Med. Chem., 2008, 4, 404-414.
76. Love, S. Oxidative stress in brain ischemia. Brain Path., 1999, 1, 119-131.
77. Dirnagl, U.; Iadecola, C.; Moskowitz, M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci., 1999, 9, 391-397.
78. Lewen, A.; Matz, P.; Chan, P.H. Free radical pathways in CNS injury. J. Neurotr., 2000, 10, 871-890.
79. Liu, S.; Liu, M.; Peterson, S.; Miyake, M.; Vallyathan, V.; Liu, K.J. Hydroxyl radical formation is greater in striatal core than in penumbra in a rat model of ischemic stroke. J. Neurosci. Res., 2003, 6, 882-888.
80. Liu, J.; Narasimhan, P.; Yu, F.; Chan, P.H. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke, 2005, 6, 1264-1269.
81. Rapino, C.; Bianchi, G.; Di Giulio, C.; Centurione, L.; Cacchio, M.; Antonucci, A.; Cataldi, A. HIF-1α cytoplasmic accumulation is associated with cell death in old rat cerebral cortex exposed to intermittent hypoxia. Aging Cell, 2005, 4, 177-185.
82. Zhang, L.; Li, L.; Liu, H.; Prabhakaran, K.; Zhang, X.; Borowitz, J.L.; Isom, G.E. HIF-1α activation by a redox-sensitive pathway mediates cyanide-induced BNIP3 upregulation and mitochondrial-dependent cell death. Free Radic. Biol. Med., 2007, 1, 117-127.
83. Peng, Y.J.; Yuan, G.; Ramakrishnan, D.; Sharma, S.D.; Bosch- Marce, M.; Kumar, G.K.; Semenza, G.L.; Prabhakar, N.R. Heterozygous HIF-1α deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J. Physiol., 2006, Pt 2, 705-716.
84. Lomb, D.J.; Desouza, L.A.; Franklin, J.L.; Freeman, R.S. Prolyl hydroxylase inhibitors depend on extracellular glucose and HIF-2α to inhibit cell death caused by NGF deprivation: evidence that HIF- 2α has a role in NGF-promoted survival of sympathetic neurons. Mol. Pharmacol., 2009, 5, 1198-1209.
85. Wellman, T.L.; Jenkins, J.; Penar, P.L.; Tranmer, B.; Zahr, R.; Lounsbury, K.M. Nitric oxide and reactive oxygen species exert opposing effects on the stability of hypoxia-inducible factor-1α in explants of human pial arteries. FASEB J., 2004, 2, 379-381.
86. Gorlach, A.; Berchner-Pfannschmidt, U.; Wotzlaw, C.; Cool, R.H.; Fandrey, J.; Acker, H.; Jungermann, K.; Kietzmann, T. Reactive oxygen species modulate HIF-1 mediated PAI-1 expression: involvement of the GTPase Rac1. Thromb. Haemost., 2003, 5, 926-935. (Pubitemid 36603435)
87. Averill-Bates, D.A.; Przybytkowski, E. The role of glucose in cellular defences against cytotoxicity of hydrogen peroxide in Chinese hamster ovary cells. Arch. Biochem. Biophys., 1994, 1, 52-58. (Pubitemid 24243798)
88. Przybytkowski, E.; Averill-Bates, D.A. Correlation between glutathione and stimulation of the pentose phosphate cycle in situ in Chinese hamster ovary cells exposed to hydrogen peroxide. Arch. Biochem. Biophys., 1996, 1, 91-98.
89. Hotta, S.S. Glucose metabolism in brain tissue: the hexosemonophosphate shunt and its role in glutathione reduction. J. Neurochem., 1962, 43-51.
90. Hotta, S.S.; Seventko, J.M., Jr. The hexosemonophosphate shunt and glutathione reduction in guinea pig brain tissue: changes caused by chlorpromazine, amytal, and malonate. Arch. Biochem. Biophys., 1968, 1, 104-108.
91. Ben-Yoseph, O.; Boxer, P.A.; Ross, B.D. Oxidative stress in the central nervous system: monitoring the metabolic response using the pentose phosphate pathway. Dev. Neurosci., 1994, 5-6, 328-336.
92. Lee, Y.J.; Galoforo, S.S.; Berns, C.M.; Chen, J.C.; Davis, B.H.; Sim, J.E.; Corry, P.M.; Spitz, D.R. Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells. J. Biol. Chem., 1998, 9, 5294-5299.
93. Ding, Q.; Dimayuga, E.; Keller, J.N. Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. Antioxid. Redox. Signal., 2006, 1-2, 163-172. (Pubitemid 43324543)
94. Ciechanover, A. The ubiquitin proteolytic system: from a vague idea, through basic mechanisms, and onto human diseases and drug targeting. Neurology, 2006, 2 Suppl 1, S7-19.
95. Wilkinson, K.D. Roles of ubiquitinylation in proteolysis and cellular regulation. Annu. Rev. Nutr., 1995, 161-189.
96. Brahimi-Horn, C.; Pouyssegur, J. When hypoxia signalling meets the ubiquitin-proteasomal pathway, new targets for cancer therapy. Crit. Rev. Oncol. Hematol., 2005, 2, 115-123. (Pubitemid 40127529)
97. Shringarpure, R.; Grune, T.; Mehlhase, J.; Davies, K.J. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J. Biol. Chem., 2003, 1, 311-318.
98. Grune, T.; Reinheckel, T.; Davies, K.J. Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J. Biol. Chem., 1996, 26, 15504-15509. (Pubitemid 26225322)
99. Grune, T.; Reinheckel, T.; Davies, K.J. Degradation of oxidized proteins in mammalian cells. FASEB J., 1997, 7, 526-534. (Pubitemid 27274426)
100. Grune, T.; Reinheckel, T.; Joshi, M.; Davies, K.J. Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J. Biol. Chem., 1995, 5, 2344-2351.
101. Callapina, M.; Zhou, J.; Schmid, T.; Kohl, R.; Brune, B. NO restores HIF-1α hydroxylation during hypoxia: role of reactive oxygen species. Free Radic. Biol. Med., 2005, 7, 925-936. (Pubitemid 43316945)
102. Elkon, H.; Melamed, E.; Offen, D. Oxidative stress, induced by 6- hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease. J. Mol. Neurosci., 2004, 3, 387-400. (Pubitemid 41389376)
103. Reinheckel, T.; Sitte, N.; Ullrich, O.; Kuckelkorn, U.; Davies, K.J.; Grune, T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem. J., 1998, 637-642. (Pubitemid 28515418)
104. Ullrich, O.; Reinheckel, T.; Sitte, N.; Hass, R.; Grune, T.; Davies, K.J. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl. Acad. Sci. USA, 1999, 11, 6223-6228.
105. Wang, G.L.; Jiang, B.H.; Semenza, G.L. Effect of altered redox states on expression and DNA-binding activity of hypoxiainducible factor 1. Biochem. Biophys. Res. Comm., 1995, 2, 550-556.
106. Kaluzova, M.; Kaluz, S.; Lerman, M.I.; Stanbridge, E.J. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1α in Hypoxic Cells and Downregulation of the Hypoxia Marker Carbonic Anhydrase IX. Mol. Cell. Biol., 2004, 13, 5757-5766.
107. Chang, S.; Jiang, X.; Zhao, C.; Lee, C.; Ferriero, D.M. Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1α protein expression and induces preconditioning protection against ischemia in primary cortical neurons. Neurosci. Lett., 2008, 1, 134-138.
108. Jahngen-Hodge, J.; Obin, M.S.; Gong, X.; Shang, F.; Nowell Jr., T.R.; Gong, J.; Abasi, H.; Blumberg, J.; Taylor, A. Regulation of ubiquitin- conjugating enzymes by glutathione following oxidative stress. J. Biol. Chem., 1997, 45, 28218-28226. (Pubitemid 27517760)
109. Lopez, A.D.; Mathers, C.D.; Ezzati, M.; Jamison, D.T.; Murray, C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 2006, 9524, 1747-1757.
110. Brown, D.L.; Barsan, W.G.; Lisabeth, L.D.; Gallery, M.E.; Morgenstern, L.B. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann. Emerg. Med., 2005, 1, 56-60. (Pubitemid 40916897)
111. Gilgun-Sherki, Y.; Rosenbaum, Z.; Melamed, E.; Offen, D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol. Rev., 2002, 2, 271-284. (Pubitemid 34575717)
112. Green, A.R.; Shuaib, A. Therapeutic strategies for the treatment of stroke. Drug Dis. Today, 2006, 15-16, 681-693.
113. Wang, C.X.; Shuaib, A. Neuroprotective effects of free radical scavengers in stroke. Drugs Aging, 2007, 7, 537-546. (Pubitemid 47195673)
114. Amaro, S.; Planas, A.M.; Chamorro, A. Uric acid administration in patients with acute stroke: a novel approach to neuroprotection. Expert Rev. Neurother., 2008, 2, 259-270. (Pubitemid 351281113)
115. Shuaib, A.; Lees, K.R.; Lyden, P.; Grotta, J.; Davalos, A.; Davis, S.M.; Diener, H.C.; Ashwood, T.; Wasiewski, W.W.; Emeribe, U. NXY-059 for the treatment of acute ischemic stroke. New Eng. J. Med., 2007, 6, 562-571. (Pubitemid 47236281)
116. Schaller, B.; Graf, R.; Jacobs, A.H. Ischaemic tolerance: a window to endogenous neuroprotection? Lancet, 2003, 9389, 1007-1008. (Pubitemid 37186874)
117. Smirnova, N.; Karan, C.; Ratan, R.; Gazaryan, I. High-throughput screening (HTPS) for HIF prolyl hydroxylase inhibitors. In Keystone Symposia Mol Cell Physiol Pathogen Respon Hypoxia, Abstract Book: Vancouber, BC, 2008, pp184.
118. Nangaku, M.; Izuhara, Y.; Yamashita, T.; Ohneda, O.; Yamamoto, M.; Miyata, T. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia. In Keystone Symposia Mol Cell Physiol Pathogen Respon Hypoxia, Abstract Book: Vancouber, BC, 2008, pp167.
119. Haque, N.; Liu, D.; Mag, V.; Kim, G.; Khansari, P.; Chou, C.; Akins, J.; Arend, M.; Flippin, L.; Sidhu, P.; Witschi, C.; Barnes, M.; Gervasi, D.; Lomongsod, E.; Klaus, S.; Porter, S.; Liu, D.; Yeowell, D.; Lin, A. Novel HIF prolyl hydroxylase inhibitors are neuroprotective in both permanent and transient rodent models of middle cerebral artery occlusion. In Keystone Symposia Mol Cell Physiol Pathogen Respon Hypoxia, Abstract Book: Vancouber, BC, 2008, pp150.